BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1066 related articles for article (PubMed ID: 18031561)

  • 41. Objective voice analysis for dysphonic patients: a multiparametric protocol including acoustic and aerodynamic measurements.
    Yu P; Ouaknine M; Revis J; Giovanni A
    J Voice; 2001 Dec; 15(4):529-42. PubMed ID: 11792029
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Reliability of clinician-based (GRBAS and CAPE-V) and patient-based (V-RQOL and IPVI) documentation of voice disorders.
    Karnell MP; Melton SD; Childes JM; Coleman TC; Dailey SA; Hoffman HT
    J Voice; 2007 Sep; 21(5):576-90. PubMed ID: 16822648
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Subjective acoustic analysis of dysphonia caused by tumor using the RBH (roughness, breathiness, hoarseness) scale].
    Mitrović S
    Srp Arh Celok Lek; 2003; 131(1-2):40-2. PubMed ID: 14608861
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Voice Tremor in Parkinson's Disease: An Acoustic Study.
    Gillivan-Murphy P; Miller N; Carding P
    J Voice; 2019 Jul; 33(4):526-535. PubMed ID: 29395332
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Subjective and perceptual analysis of voice quality and relationship with neurological disfunction in multiple sclerosis patients.
    Bauer V; Aleric Z; Jancic E; Knezevic B; Prpic D; Kacavenda A
    Clin Neurol Neurosurg; 2013 Dec; 115 Suppl 1():S17-20. PubMed ID: 24321149
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Treatment algorithm for patients with puberphonia].
    Kizilay A; Firat Y
    Kulak Burun Bogaz Ihtis Derg; 2008; 18(6):335-42. PubMed ID: 19293621
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Spectral analysis of the voice in Down Syndrome.
    Albertini G; Bonassi S; Dall'Armi V; Giachetti I; Giaquinto S; Mignano M
    Res Dev Disabil; 2010; 31(5):995-1001. PubMed ID: 20488659
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Executive dysfunction using behavioral assessment of the dysexecutive syndrome in Parkinson's disease.
    Kamei S; Hara M; Serizawa K; Murakami M; Mizutani T; Ishiburo M; Kawahara R; Takagi Y; Ogawa K; Yoshihashi H; Shinbo S; Suzuki Y; Yamaguchi M; Morita A; Takeshita J; Hirayanagi K
    Mov Disord; 2008 Mar; 23(4):566-73. PubMed ID: 18098279
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Survey of Voice Acoustic Parameters in Iranian Female Teachers.
    Mohseni R; Sandoughdar N
    J Voice; 2016 Jul; 30(4):507.e1-5. PubMed ID: 26275636
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Functional voice outcomes after thyroidectomy: an assessment of the Dsyphonia Severity Index (DSI) after thyroidectomy.
    Henry LR; Helou LB; Solomon NP; Howard RS; Gurevich-Uvena J; Coppit G; Stojadinovic A
    Surgery; 2010 Jun; 147(6):861-70. PubMed ID: 20096434
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The Psychometric Properties of the Voice Handicap Index in People With Parkinson's Disease.
    Guimaraes I; Cardoso R; Pinto S; Ferreira JJ
    J Voice; 2017 Mar; 31(2):258.e13-258.e18. PubMed ID: 27397112
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Immediate post-operative vocal changes in patients using laryngeal mask airway versus endotracheal tube.
    Hamdan AL; Kanazi G; Rameh C; Rifai H; Sibai A
    J Laryngol Otol; 2008 Aug; 122(8):829-35. PubMed ID: 17617935
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The voice handicap index: correlation between subjective patient response and quantitative assessment of voice.
    Woisard V; Bodin S; Yardeni E; Puech M
    J Voice; 2007 Sep; 21(5):623-31. PubMed ID: 16887329
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Factors predicting patient perception of dysphonia caused by benign vocal fold lesions.
    Behrman A; Sulica L; He T
    Laryngoscope; 2004 Oct; 114(10):1693-700. PubMed ID: 15454756
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Bilateral impairments of skilled reach-to-eat in early Parkinson's disease patients presenting with unilateral or asymmetrical symptoms.
    Doan JB; Melvin KG; Whishaw IQ; Suchowersky O
    Behav Brain Res; 2008 Dec; 194(2):207-13. PubMed ID: 18692094
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The voice handicap index as a tool for assessment of the biopsychosocial impact of voice problems.
    Maertens K; de Jong FI
    B-ENT; 2007; 3(2):61-6. PubMed ID: 17685046
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The range and nature of sleep dysfunction in untreated Parkinson's disease (PD). A comparative controlled clinical study using the Parkinson's disease sleep scale and selective polysomnography.
    Dhawan V; Dhoat S; Williams AJ; Dimarco A; Pal S; Forbes A; Tobías A; Martinez-Martin P; Chaudhuri KR
    J Neurol Sci; 2006 Oct; 248(1-2):158-62. PubMed ID: 16780888
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Percutaneous corticosteroid injection for vocal fold polyp.
    Hsu YB; Lan MC; Chang SY
    Arch Otolaryngol Head Neck Surg; 2009 Aug; 135(8):776-80. PubMed ID: 19687397
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Computerized method for arm movement assessment in Parkinson's disease and cerebellar syndrome patients].
    Dordević O; Popović MB; Kostić V
    Srp Arh Celok Lek; 2005; 133(1-2):14-20. PubMed ID: 16053170
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Restless legs syndrome in Parkinson's disease.
    Gómez-Esteban JC; Zarranz JJ; Tijero B; Velasco F; Barcena J; Rouco I; Lezcano E; Lachen MC; Jauregui A; Ugarte A
    Mov Disord; 2007 Oct; 22(13):1912-6. PubMed ID: 17579369
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 54.